WebMD Health Corp. (NASDAQ:WBMD)‘s stock had its “buy” rating reiterated by stock analysts at Leerink Swann in a research report issued on Wednesday.

The analysts wrote, “We are somewhat surprised by the CEO change, given the company’s strong performance particularly over the last year. However from our conversation with the company we believe Dr. Zatz has been running many of the day-to-day operations of the business and he is viewed as a strong internal leader both by customers and employees of the business. Given Dr.””

A number of other research analysts also recently issued reports on WBMD. Vetr upgraded shares of WebMD Health Corp. from a “hold” rating to a “buy” rating and set a $68.50 price target on the stock in a research report on Tuesday, May 24th. William Blair downgraded shares of WebMD Health Corp. from an “outperform” rating to a “market perform” rating in a research report on Friday, June 3rd. They noted that the move was a valuation call. Royal Bank Of Canada restated an “outperform” rating and issued a $75.00 price target on shares of WebMD Health Corp. in a research report on Wednesday, June 22nd. Zacks Investment Research downgraded shares of WebMD Health Corp. from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 6th. Finally, Mizuho initiated coverage on shares of WebMD Health Corp. in a research report on Monday, July 11th. They issued a “buy” rating and a $68.00 price target on the stock. Five investment analysts have rated the stock with a hold rating, six have given a buy rating and two have issued a strong buy rating to the company. WebMD Health Corp. presently has an average rating of “Buy” and an average target price of $64.79.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/webmd-health-corp-s-wbmd-buy-rating-reaffirmed-at-leerink-swann.html

Shares of WebMD Health Corp. (NASDAQ:WBMD) traded up 0.06% on Wednesday, reaching $48.93. 110,442 shares of the company traded hands. WebMD Health Corp. has a one year low of $37.89 and a one year high of $67.55. The firm has a 50-day moving average price of $53.16 and a 200 day moving average price of $59.33. The company has a market capitalization of $1.84 billion, a PE ratio of 30.13 and a beta of 0.70.

WebMD Health Corp. (NASDAQ:WBMD) last issued its quarterly earnings results on Monday, August 8th. The company reported $0.39 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.38 by $0.01. The firm had revenue of $167.60 million for the quarter, compared to the consensus estimate of $165.46 million. WebMD Health Corp. had a net margin of 11.05% and a return on equity of 40.02%. The company’s revenue for the quarter was up 13.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.32 EPS. Equities analysts forecast that WebMD Health Corp. will post $1.82 EPS for the current fiscal year.

A number of hedge funds have recently made changes to their positions in the stock. Meeder Asset Management Inc. acquired a new stake in shares of WebMD Health Corp. during the first quarter worth approximately $115,000. LS Investment Advisors LLC purchased a new stake in WebMD Health Corp. during the second quarter valued at about $134,000. BlackRock Inc. raised its stake in WebMD Health Corp. by 131.1% in the first quarter. BlackRock Inc. now owns 2,491 shares of the company’s stock valued at $156,000 after buying an additional 1,413 shares during the last quarter. Parametrica Management Ltd purchased a new stake in WebMD Health Corp. during the first quarter valued at about $203,000. Finally, Tower Research Capital LLC TRC raised its stake in WebMD Health Corp. by 11,003.1% in the second quarter. Tower Research Capital LLC TRC now owns 3,553 shares of the company’s stock valued at $207,000 after buying an additional 3,521 shares during the last quarter. Institutional investors and hedge funds own 84.19% of the company’s stock.

About WebMD Health Corp.

WebMD Health Corp. is a provider of health information services. The Company provides its services to consumers, physicians and other healthcare professionals, employers and health plans through its public and private online portals, mobile platforms and health-focused publications. The WebMD Health Network includes: www.WebMD.com, its primary public portal for consumers and related mobile-optimized sites and mobile apps; www.Medscape.com, its primary public portal for physicians and other healthcare professionals and related mobile services; and other sites through which, the Company provides its branded health and wellness content, tools and services.

5 Day Chart for NASDAQ:WBMD

Receive News & Ratings for WebMD Health Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WebMD Health Corp. and related companies with MarketBeat.com's FREE daily email newsletter.